Results 141 to 150 of about 340,736 (281)

A Novel Deep Arrhythmia-Diagnosis Network for Atrial Fibrillation Classification Using Electrocardiogram Signals [PDF]

, 2019
Hao Dang, Muyi Sun, Guanhong Zhang, Xingqun Qi, Xiaoguang Zhou, Qing Chang   +5 more
openalex   +1 more source

Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation

, 2023
Tze‐Fan Chao, Ngai‐Yin Chan, Yi‐Hsin Chan, Min-Soo Cho, Rungroj Krittayaphong, Kwang‐No Lee, Shaowen Liu, Tachapong Ngamukos, Hung‐Fat Tse   +8 more
openalex   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

, 2014
Benjamin A. Steinberg, Sunghee Kim, Gregg C. Fonarow, Laine Thomas, Jack Ansell, Peter R. Kowey, Kenneth W. Mahaffey, Bernard J. Gersh, Elaine M. Hylek, Gerald V. Naccarelli, Alan S. Go, James A. Reiffel, Paul Chang, Eric D. Peterson, Jonathan P. Piccini   +14 more
openalex   +1 more source

VErapamil Plus Antiarrhythmic drugs Reduce Atrial Fibrillation recurrences after an electrical cardioversion (VEPARAF Study) [PDF]

, 2003
Antonio De Simone
openalex   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Artificial intelligence for atrial fibrillation detection, prediction, and treatment: A systematic review of the last decade (2013–2023) [PDF]

Massimo Salvi, Madhav R. Acharya, Silvia Seoni, Oliver Faust, Ru‐San Tan, Prabal Datta Barua, Salvador García, Filippo Molinari, U. Rajendra Acharya   +8 more
openalex   +1 more source

Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE‐AF [PDF]

, 2019
Jane S. Saczynski, Saket Sanghai, Catarina I. Kiefe, Darleen Lessard, Francesca Marino, Molly E. Waring, David C. Parish, Robert Helm, Felix Sogade, Robert J. Goldberg, Jerry H. Gurwitz, Weijia Wang, Tanya Mailhot, Benita A. Bamgbade, Bruce Barton, David D. McManus   +15 more
openalex   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Zbtb16 increases susceptibility of atrial fibrillation in type 2 diabetic mice via Txnip-Trx2 signaling [PDF]

Zhixing Wei, Xingxing Cai, Yudong Fei, Qian Wang, Xiaoliang Hu, Cheng Li, Jian-Wen Hou, Yuli Yang, Tai-Zhong Chen, Xiaolei Xu, Yuepeng Wang, Yi‐Gang Li   +11 more
openalex   +1 more source